Clinical Trials Browser

Phase 1 × OTHER_GOV × Dasatinib × Clear all

NCT03414450 2018-10-25

Evaluation of ETC-1907206 With Dasatinib in Advanced Haematologic Malignancies

Phase 1 Withdrawn

Other hematologic neoplasm

Leukemia, Myeloid, Accelerated Phase